{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:16:48Z","timestamp":1780046208675,"version":"3.53.1"},"reference-count":60,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"5","funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","award":["R03MH08744, R01MH095088"],"award-info":[{"award-number":["R03MH08744, R01MH095088"]}],"id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","award":["286334"],"award-info":[{"award-number":["286334"]}],"id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Netherlands Genomics Initiative","award":["050-060-452"],"award-info":[{"award-number":["050-060-452"]}]},{"name":"Dutch Fund for Economic Structure Reinforcement","award":["0908"],"award-info":[{"award-number":["0908"]}]},{"name":"Virgo consortium, funded by the Dutch Government","award":["FES0908"],"award-info":[{"award-number":["FES0908"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2019,5,3]]},"abstract":"<jats:p>High-content functional screening of primary patient blood cells reveals repurposed psychiatric drug candidates.<\/jats:p>","DOI":"10.1126\/sciadv.aau9093","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T23:15:23Z","timestamp":1557357323000},"source":"Crossref","is-referenced-by-count":28,"title":["Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo"],"prefix":"10.1126","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6345-1499","authenticated-orcid":true,"given":"Santiago G.","family":"Lago","sequence":"first","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2127-4487","authenticated-orcid":true,"given":"Jakub","family":"Tomasik","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9431-0653","authenticated-orcid":true,"given":"Geertje F.","family":"van Rees","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Steeb","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Rustogi","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M.","family":"Ramsey","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Bishop","sequence":"additional","affiliation":[{"name":"Chemical Neurobiology Laboratory, Departments of Neurology and Psychiatry, Massachusetts General Hospital, Center for Genomic Medicine, Harvard Medical School, Boston, MA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7972-4612","authenticated-orcid":true,"given":"Tracey","family":"Petryshen","sequence":"additional","affiliation":[{"name":"Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA."},{"name":"Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA."},{"name":"Department of Psychiatry, Harvard Medical School, Boston, MA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Haggarty","sequence":"additional","affiliation":[{"name":"Chemical Neurobiology Laboratory, Departments of Neurology and Psychiatry, Massachusetts General Hospital, Center for Genomic Medicine, Harvard Medical School, Boston, MA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"V\u00e1zquez-Bourgon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Marqu\u00e9s de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain."},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental (CIBERSAM), Santander, Spain."},{"name":"IDIVAL, Valdecilla Biomedical Research Institute, Santander, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9366-8728","authenticated-orcid":true,"given":"Sergi","family":"Papiol","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental (CIBERSAM), Barcelona, Spain."},{"name":"Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, Ludwig Maximilian University, Munich, Germany."},{"name":"Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Suarez-Pinilla","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Marqu\u00e9s de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain."},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental (CIBERSAM), Santander, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0033-7132","authenticated-orcid":true,"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Marqu\u00e9s de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain."},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental (CIBERSAM), Santander, Spain."},{"name":"IDIVAL, Valdecilla Biomedical Research Institute, Santander, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico J.","family":"van Beveren","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Erasmus Medical Centre, Rotterdam, Netherlands."},{"name":"Department of Psychiatry, Erasmus Medical Centre, Rotterdam, Netherlands."},{"name":"Department \u201cNieuwe Kennis,\u201d Delta Centre for Mental Health Care, Rotterdam, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4690-6302","authenticated-orcid":true,"given":"Sabine","family":"Bahn","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2217"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07454","article-title":"A glimmer of light for neuropsychiatric disorders","volume":"455","author":"Hyman S. E.","year":"2008","unstructured":"S. E. Hyman, A glimmer of light for neuropsychiatric disorders. Nature 455, 890\u2013893 (2008).","journal-title":"Nature"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nrd1303","article-title":"From monoamines to genomic targets: A paradigm shift for drug discovery in depression","volume":"3","author":"Wong M.-L.","year":"2004","unstructured":"M.-L. Wong, J. Licinio, From monoamines to genomic targets: A paradigm shift for drug discovery in depression. Nat. Rev. Drug Discov. 3, 136\u2013151 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","article-title":"Schizophrenia","volume":"1","author":"Kahn R. S.","year":"2015","unstructured":"R. S. Kahn, I. E. Sommer, R. M. Murray, A. Meyer-Lindenberg, D. R. Weinberger, T. D. Cannon, M. O'Donovan, C. U. Correll, J. M. Kane, J. van Os, T. R. Insel, Schizophrenia. Nat. Rev. Dis. Primers 1, 15067 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamapsychiatry.2014.112","article-title":"Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: A systematic overview of meta-analyses","volume":"71","author":"Huhn M.","year":"2014","unstructured":"M. Huhn, M. Tardy, L. M. Spineli, W. Kissling, H. F\u00f6rstl, G. Pitschel-Walz, C. Leucht, M. Samara, M. Dold, J. M. Davis, S. Leucht, Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: A systematic overview of meta-analyses. JAMA Psychiat. 71, 706\u2013715 (2014).","journal-title":"JAMA Psychiat."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbi.2015.10.019","article-title":"Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients","volume":"52","author":"Tomasik J.","year":"2016","unstructured":"J. Tomasik, E. Schwarz, S. G. Lago, M. Rothermundt, F. M. Leweke, N. J. M. van Beveren, P. C. Guest, H. Rahmoune, J. Steiner, S. Bahn, Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients. Brain Behav. Immun. 52, 178\u2013186 (2016).","journal-title":"Brain Behav. Immun."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature13595"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2711"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0092-1"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09915"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-017-0005-8"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2317"},{"key":"e_1_3_2_14_2","article-title":"Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks","author":"Lago S. G.","year":"2018","unstructured":"S. G. Lago, J. Tomasik, G. F. van Rees, J. M. Ramsey, F. Haenisch, J. D. Cooper, J. A. Broek, P. Suarez-Pinilla, T. Ruland, B. Auyeug, O. Mikova, N. Kabacs, V. Arolt, S. Baron-Cohen, B. Crespo-Facorro, S. Bahn, Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks. Mol. Psychiatry, 10.1038\/s41380-018-0123-4 (2018).","journal-title":"Mol. Psychiatry"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.04.013"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/mp.2010.71","article-title":"Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients","volume":"16","author":"Herberth M.","year":"2011","unstructured":"M. Herberth, D. Koethe, T. M. K. Cheng, N. D. Krzyszton, S. Schoeffmann, P. C. Guest, H. Rahmoune, L. W. Harris, L. Kranaster, F. M. Leweke, S. Bahn, Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients. Mol. Psychiatry 16, 848\u2013859 (2011).","journal-title":"Mol. Psychiatry"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pnpbp.2004.01.009","article-title":"Lymphocytes as a neural probe: Potential for studying psychiatric disorders","volume":"28","author":"Gladkevich A.","year":"2004","unstructured":"A. Gladkevich, H. F. Kauffman, J. Korf, Lymphocytes as a neural probe: Potential for studying psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 559\u2013576 (2004).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3\u03b2 signaling in schizophrenia","volume":"36","author":"Emamian E. S.","year":"2004","unstructured":"E. S. Emamian, D. Hall, M. J. Birnbaum, M. Karayiorgou, J. A. Gogos, Convergent evidence for impaired AKT1-GSK3\u03b2 signaling in schizophrenia. Nat. Genet. 36, 131\u2013137 (2004).","journal-title":"Nat. Genet."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/npp.2010.43","article-title":"Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances","volume":"35","author":"Polter A.","year":"2010","unstructured":"A. Polter, E. Beurel, S. Yang, R. Garner, L. Song, C. A. Miller, J. D. Sweatt, L. McMahon, A. A. Bartolucci, X. Li, R. S. Jope, Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology 35, 1761\u20131774 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jad.2014.03.011","article-title":"Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy","volume":"163","author":"Rivera-Baltanas T.","year":"2014","unstructured":"T. Rivera-Baltanas, J. M. Olivares, J. R. Martinez-Villamarin, E. Y. Fenton, L. E. Kalynchuk, H. J. Caruncho, Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy. J. Affect. Disord. 163, 47\u201355 (2014).","journal-title":"J. Affect. Disord."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ajmg.b.32679","article-title":"Genotype-phenotype correlations in Darier disease: A focus on the neuropsychiatric phenotype","volume":"177","author":"Gordon-Smith K.","year":"2018","unstructured":"K. Gordon-Smith, E. Green, D. Grozeva, S. Tavadia, N. Craddock, L. Jones, Genotype-phenotype correlations in Darier disease: A focus on the neuropsychiatric phenotype. Am. J. Med. Genet. B Neuropsychiatr. Genet. 177, 717\u2013726 (2018).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/YCO.0000000000000466","article-title":"Recent developments in understanding the relationship between 22q11.2 deletion syndrome and psychosis","volume":"32","author":"O\u2019Rourke L.","year":"2019","unstructured":"L. O\u2019Rourke, K. Murphy, Recent developments in understanding the relationship between 22q11.2 deletion syndrome and psychosis. Curr. Opin. Psychiatry 32, 67\u201372 (2019).","journal-title":"Curr. Opin. Psychiatry"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/mp.2016.50","article-title":"From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways","volume":"21","author":"Rogers G. B.","year":"2016","unstructured":"G. B. Rogers, D. J. Keating, R. L. Young, M.-L. Wong, J. Licinio, S. Wesselingh, From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways. Mol. Psychiatry 21, 738\u2013748 (2016).","journal-title":"Mol. Psychiatry"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2297"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.07.001"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.038"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.230"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth872"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nchembio.2007.59","article-title":"High-content single-cell drug screening with phosphospecific flow cytometry","volume":"4","author":"Krutzik P. O.","year":"2008","unstructured":"P. O. Krutzik, J. M. Crane, M. R. Clutter, G. P. Nolan, High-content single-cell drug screening with phosphospecific flow cytometry. Nat. Chem. Biol. 4, 132\u2013142 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.4049\/jimmunol.1101804","article-title":"T cell-signaling network analysis reveals distinct differences between CD28 and CD2 costimulation responses in various subsets and in the MAPK pathway between resting and activated regulatory T cells","volume":"187","author":"Kalland M. E.","year":"2011","unstructured":"M. E. Kalland, N. G. Oberprieler, T. Vang, K. Task\u00e9n, K. M. Torgersen, T cell-signaling network analysis reveals distinct differences between CD28 and CD2 costimulation responses in various subsets and in the MAPK pathway between resting and activated regulatory T cells. J. Immunol. 187, 5233\u20135245 (2011).","journal-title":"J. Immunol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"11607","DOI":"10.1073\/pnas.96.20.11607","article-title":"D2 dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons","volume":"96","author":"Yan Z.","year":"1999","unstructured":"Z. Yan, J. Feng, A. A. Fienberg, P. Greengard, D2 dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc. Natl. Acad. Sci. U.S.A. 96, 11607\u201311612 (1999).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198704"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1503\/jpn.110011","article-title":"A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health","volume":"37","author":"Beaulieu J.-M.","year":"2012","unstructured":"J.-M. Beaulieu, A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J. Psychiatry Neurosci. 37, 7\u201316 (2012).","journal-title":"J. Psychiatry Neurosci."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.6b00306"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.24"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1346"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/schbul\/sbu045","article-title":"Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes","volume":"40","author":"Luo X.","year":"2014","unstructured":"X. Luo, L. Huang, L. Han, Z. Luo, F. Hu, R. Tieu, L. Gan, Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes. Schizophr. Bull. 40, 1285\u20131299 (2014).","journal-title":"Schizophr. Bull."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1755-5949.2010.00203.x","article-title":"Histone deacetylases and mood disorders: Epigenetic programming in gene-environment interactions","volume":"17","author":"Machado-Vieira R.","year":"2011","unstructured":"R. Machado-Vieira, L. Ibrahim, C. A. Zarate Jr., Histone deacetylases and mood disorders: Epigenetic programming in gene-environment interactions. CNS Neurosci. Ther. 17, 699\u2013704 (2011).","journal-title":"CNS Neurosci. Ther."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1038\/tp.2012.104","article-title":"Convergent animal and human evidence suggests the activin\/inhibin pathway to be involved in antidepressant response","volume":"2","author":"Ganea K.","year":"2012","unstructured":"K. Ganea, A. Menke, M. V. Schmidt, S. Lucae, G. Rammes, C. Liebl, D. Harbich, V. Sterlemann, C. Storch, M. Uhr, F. Holsboer, E. B. Binder, I. Sillaber, M. B. M\u00fcller, Convergent animal and human evidence suggests the activin\/inhibin pathway to be involved in antidepressant response. Transl. Psychiatry 2, e177 (2012).","journal-title":"Transl. Psychiatry"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.biopsych.2006.05.047","article-title":"A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment","volume":"61","author":"Duman C. H.","year":"2007","unstructured":"C. H. Duman, L. Schlesinger, M. Kodama, D. S. Russell, R. S. Duman, A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol. Psychiatry 61, 661\u2013670 (2007).","journal-title":"Biol. Psychiatry"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12975"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00243"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jbior.2015.11.003","article-title":"Primary phospholipase C and brain disorders","volume":"61","author":"Yang Y. R.","year":"2016","unstructured":"Y. R. Yang, D.-S. Kang, C. Lee, H. Seok, M. Y. Follo, L. Cocco, P.-G. Suh, Primary phospholipase C and brain disorders. Adv. Biol. Regul. 61, 80\u201385 (2016).","journal-title":"Adv. Biol. Regul."},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/mp.2016.261","article-title":"Forebrain-specific ablation of phospholipase C\u03b31 causes manic-like behavior","volume":"22","author":"Yang Y. R.","year":"2017","unstructured":"Y. R. Yang, J. H. Jung, S.-J. Kim, K. Hamada, A. Suzuki, H. J. Kim, J. H. Lee, O.-B. Kwon, Y. K. Lee, J. Kim, E.-K. Kim, H.-J. Jang, D.-S. Kang, J.-S. Choi, C. J. Lee, J. Marshall, H.-Y. Koh, C.-J. Kim, H. Seok, S. H. Kim, J. H. Choi, Y.-B. Choi, L. Cocco, S. H. Ryu, J.-H. Kim, P.-G. Suh, Forebrain-specific ablation of phospholipase C\u03b31 causes manic-like behavior. Mol. Psychiatry 22, 1473\u20131482 (2017).","journal-title":"Mol. Psychiatry"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00441-014-1806-z","article-title":"Calcium signalling and psychiatric disease: Bipolar disorder and schizophrenia","volume":"357","author":"Berridge M. J.","year":"2014","unstructured":"M. J. Berridge, Calcium signalling and psychiatric disease: Bipolar disorder and schizophrenia. Cell Tissue Res. 357, 477\u2013492 (2014).","journal-title":"Cell Tissue Res."},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbior.2012.09.008","article-title":"Phospholipase C-\u03b31 involved in brain disorders","volume":"53","author":"Jang H.-J.","year":"2013","unstructured":"H.-J. Jang, Y. R. Yang, J. K. Kim, J. H. Choi, Y.-K. Seo, Y. H. Lee, J. E. Lee, S. H. Ryu, P.-G. Suh, Phospholipase C-\u03b31 involved in brain disorders. Adv. Biol. Regul. 53, 51\u201362 (2013).","journal-title":"Adv. Biol. Regul."},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fncel.2014.00370","article-title":"Microglial intracellular Ca2+ signaling as a target of antipsychotic actions for the treatment of schizophrenia","volume":"8","author":"Mizoguchi Y.","year":"2014","unstructured":"Y. Mizoguchi, T. A. Kato, H. Horikawa, A. Monji, Microglial intracellular Ca2+ signaling as a target of antipsychotic actions for the treatment of schizophrenia. Front. Cell. Neurosci. 8, 370 (2014).","journal-title":"Front. Cell. Neurosci."},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12035-012-8293-6","article-title":"Calcium-dependent networks in dopamine-glutamate interaction: The role of postsynaptic scaffolding proteins","volume":"46","author":"de Bartolomeis A.","year":"2012","unstructured":"A. de Bartolomeis, C. Tomasetti, Calcium-dependent networks in dopamine-glutamate interaction: The role of postsynaptic scaffolding proteins. Mol. Neurobiol. 46, 275\u2013296 (2012).","journal-title":"Mol. Neurobiol."},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0166-2236(03)00022-5","article-title":"Receptor tyrosine kinase transactivation: Fine-tuning synaptic transmission","volume":"26","author":"Ferguson S. S. G.","year":"2003","unstructured":"S. S. G. Ferguson, Receptor tyrosine kinase transactivation: Fine-tuning synaptic transmission. Trends Neurosci. 26, 119\u2013122 (2003).","journal-title":"Trends Neurosci."},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2315","article-title":"Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors","volume":"17","author":"Pitcher G. M.","year":"2011","unstructured":"G. M. Pitcher, L. V. Kalia, D. Ng, N. M. Goodfellow, K. T. Yee, E. K. Lambe, M. W. Salter, Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat. Med. 17, 470\u2013478 (2011).","journal-title":"Nat. Med."},{"key":"e_1_3_2_51_2","first-page":"192","article-title":"Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients","volume":"10","author":"Iglesias Garc\u00eda C.","year":"2017","unstructured":"C. Iglesias Garc\u00eda, A. Iglesias Alonso, J. Bobes, Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients. Rev. Psiquiatr. Salud Ment. 10, 192\u2013196 (2017).","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/mp.2015.28","article-title":"Targeting the schizophrenia genome: A fast track strategy from GWAS to clinic","volume":"20","author":"Lencz T.","year":"2015","unstructured":"T. Lencz, A. K. Malhotra, Targeting the schizophrenia genome: A fast track strategy from GWAS to clinic. Mol. Psychiatry 20, 820\u2013826 (2015).","journal-title":"Mol. Psychiatry"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0278-5846(83)90103-3","article-title":"The influence of nisoldipine\u2014A \u201ccalcium entry blocker\u201d on drug induced stereotyped behavior in rats","volume":"7","author":"Shah A. B.","year":"1983","unstructured":"A. B. Shah, R. M. Poiletman, N. S. Shah, The influence of nisoldipine\u2014A \u201ccalcium entry blocker\u201d on drug induced stereotyped behavior in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 7, 165\u2013173 (1983).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000028195","article-title":"Differentiation of the inhibitory effects of calcium antagonists on abnormal behaviors induced by methamphetamine or phencyclidine","volume":"56","author":"Hori Y.","year":"1998","unstructured":"Y. Hori, H. Takeda, M. Tsuji, T. Matsumiya, Differentiation of the inhibitory effects of calcium antagonists on abnormal behaviors induced by methamphetamine or phencyclidine. Pharmacology 56, 165\u2013174 (1998).","journal-title":"Pharmacology"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nchembio.1690","article-title":"GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitors","volume":"11","author":"Thorne C. A.","year":"2015","unstructured":"C. A. Thorne, C. Wichaidit, A. D. Coster, B. A. Posner, L. F. Wu, S. J. Altschuler, GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitors. Nat. Chem. Biol. 11, 58\u201363 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1176\/appi.ajp.2011.11010048","article-title":"Diagnostic shifts during the decade following first admission for psychosis","volume":"168","author":"Bromet E. J.","year":"2011","unstructured":"E. J. Bromet, R. Kotov, L. J. Fochtmann, G. A. Carlson, M. Tanenberg-Karant, C. Ruggero, S.-w. Chang, Diagnostic shifts during the decade following first admission for psychosis. Am. J. Psychiatry 168, 1186\u20131194 (2011).","journal-title":"Am. J. Psychiatry"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S1461145708009358","article-title":"Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder","volume":"12","author":"Hayashi A.","year":"2009","unstructured":"A. Hayashi, T. Kasahara, M. Kametani, T. Toyota, T. Yoshikawa, T. Kato, Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder. Int. J. Neuropsychopharmacol. 12, 33\u201343 (2009).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1991"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2594"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/msb4100116","article-title":"Chemical combination effects predict connectivity in biological systems","volume":"3","author":"Leh\u00e1r J.","year":"2007","unstructured":"J. Leh\u00e1r, G. R. Zimmermann, A. S. Krueger, R. A. Molnar, J. T. Ledell, A. M. Heilbut, G. F. Short, L. C. Giusti, G. P. Nolan, O. A. Magid, M. S. Lee, A. A. Borisy, B. R. Stockwell, C. T. Keith, Chemical combination effects predict connectivity in biological systems. Mol. Syst. Biol. 3, 80 (2007).","journal-title":"Mol. Syst. Biol."},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv402"}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aau9093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T17:01:17Z","timestamp":1704819677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aau9093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,3]]}},"alternative-id":["10.1126\/sciadv.aau9093"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aau9093","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"article-number":"eaau9093"}}